Synthesis of osteoprotegerin and RANKL by megakaryocytes is modulated by oestrogen

British Journal of Haematology

Volumn 126, Issue 2, 2004, Pages 244-251

  Bord, S ^a   Frith, E ^a,b   Ireland, D C ^a   Scott, M A ^b   Craig, J I O ^b   Compston, J E ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Bone remodelling; Immunocytochemistry; Megakaryocytopoiesis; Oestradiol

Indexed keywords

CD61 ANTIGEN; ESTRADIOL; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ARTICLE; BONE REMODELING; CELL CULTURE; CONTROLLED STUDY; FLUORESCENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOLOCALIZATION; MEGAKARYOCYTE; MEGAKARYOPOIESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS;

CARRIER PROTEINS; CELLS, CULTURED; ESTRADIOL; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MEGAKARYOCYTES; MEMBRANE GLYCOPROTEINS; OSTEOPROTEGERIN; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER;

EID: 3242682383     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.05024.x     Document Type: Article

References (40)

1. Anderson, D.M., Maraskovsky, E., Billingsley, W.L., Dougall, W.C., Tometsko, M.E., Roux, E.R., Teepe, M.C., DuBose, R.F., Cosman, D. & Galibert, L. (1997) A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature, 390, 175-179.
2. Armitage, P. & Berry, G. (1994) Statistical Inference. Blackwall Science Ltd, Oxford.
3. Bord, S., Vedi, S., Beavan, S.R., Horner, A. & Compston, J.E. (2000) Megakaryocyte population in human bone marrow increases with estrogen treatment: a role in bone remodeling? Bone, 27, 397-401.
4. Bord, S., Beavan, S., Ireland, D., Horner, A. & Compston, J.E. (2001) Mechanisms by which high-dose estrogen therapy produces anabolic skeletal effects in postmenopausal women: role of locally produced growth factors. Bone, 29, 216-222.
5. Bord, S., Frith, E., Ireland, D.C., Scott, M.A., Craig, J.I.O. & Compston, J.E. (2002) Estrogen stimulates megakaryocyte differentiation and estrogen receptor protein and mRNA expression. Journal of Bone and Mineral Research, 17, OC2.
6. Bord, S., Frith, E., Ireland, D.C., Scott, M.A., Craig, J.I.O. & Compston, J.E. (2004) Estrogen stimulates differentiation of megakaryocytes and modulates their expression of estrogen receptors a and b. Journal of Cellular Biochemistry, 92, 249-257.
7. Braidman, I.P., Hainey, L., Batra, G., Selby, P.L., Saunders, P.T.K. & Hoyland, J.A. (2001) Localization of estrogen receptor beta protein expression in adult human bone. Journal of Bone and Mineral Research, 16, 214-220.
8. Brzozowski, A.M., Pike, A.C.W., Dauter, Z., Hubbard, R.E., Bonn, T., Engstrom, O., Ohman, L., Greene, G.L., Gustafsson, J.A. & Carlquist, M. (1997) Molecular basis of agonism and antagonism in the oestrogen receptor. Nature, 389, 753-758.
9. Bucay, N., Sarosi, I., Dunstan, C.R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H.L., Xu, W.L., Lacey, D.L., Boyle, W.J. & Simonet, W.S. (1998) Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes & Development, 12, 1260-1268.
10. Chagraoui, H., Sabri, S., Capron, C., Villeval, J.-L., Vainchenker, W. & Wendling, F. (2003) Expression of osteoprotegerin mRNA and protein in murine megakaryocytes. Experimental Hematology, 31, 1081-1088.
11. Chow, J., Tobias, J.H., Colston, K.W. & Chambers, T.J. (1992) Estrogen maintains trabecular bone volume in rats not only by suppression of bone resorption but also by stimulation of bone formation. Journal of Clinical Investigation, 89, 74-78.
12. Compston, J.E. (2002) Bone marrow and bone: a functional unit. Journal of Endocrinology, 173, 387-394.
13. Croucher, P.I., Shipman, C.M., Lippitt, J., Perry, M., Asosingh, K., Hijzen, A., Brabbs, A.C., van Beek, E.J.R., Holen, I., Skerry, T.M., Dunstan, C.R., Russell, G.R., Van Camp, B. & Vanderkerken, K. (2001) Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma. Blood, 98, 3534-3540.
14. Edwards, M.W., Bain, S.D., Bailey, M.C., Lantry, M.M. & Howard, G.A. (1992) 17-beta-estradiol stimulation of endosteal bone-formation in the ovariectomized mouse - an animal-model for the evaluation of bone-targeted estrogens. Bone, 13, 29-34.
15. Ellis, M.H., Avraham, H. & Groopman, J.E. (1995) The regulation of megakaryocytopoiesis. Blood Reviews, 9, 1-6.
16. Fink, L., Seeger, W., Ermert, L., Hanze, J., Stahl, U., Grimminger, F., Kummer, W. & Bohle, R.M. (1998) Real-time quantitative RT-PCR after laser-assisted cell picking. Nature Medicine, 4, 1329-1333.
17. Fuller, K., Owens, J.M. & Chambers, T.J. (1998) Induction of osteoclast formation by parathyroid hormone depends on an action on stromal cells. Journal of Endocrinology, 158, 341-350.
18. Genever, P.G., Wilkinson, D.J.P., Patton, A.J., Peet, N.M., Hong, Y., Mathur, A., Erusalimsky, J.D. & Skerry, T.M. (1999) Expression of a functional N-methyl-D-aspartate-type glutamate receptor by bone marrow megakaryocytes. Blood, 93, 2876-2883.
19. Harris, S.A., Tau, K.R., Turner, R.T. & Spelsberg, T.C. (1996) Estrogens and progestins. In: Principles in Bone Biology (ed. by J.P. Bilezikian, L.G. Raisz & G.A. Rodan), pp. 507-520. Academic Press, New York.
20. Hoffman, R., Straneva, J., Yang, H.H., Bruno, E. & Brandt, J. (1987) New insights into the regulation of human megakaryocytopoiesis. Blood Cells, 13, 75-86.
21. House, M.G., Kohlmeier, L., Chattopadhyay, N., Kifor, O., Yamaguchi, T., Leboff, M.S., Glowacki, J. & Brown, E.M. (1997) Expression of an extracellular calcium-sensing receptor in human and mouse bone marrow cells. Journal of Bone and Mineral Research, 12, 1959-1970.
22. Ireland, D.C., Bord, S., Beavan, S.R. & Compston, J.E. (2002) Effects of estrogen on collagen synthesis by cultured human osteoblasts depend on the rate of cellular differentiation. Journal of Cellular Biochemistry, 86, 251-257.
23. Kartsogiannis, V., Zhou, H., Horwood, N.J., Thomas, R.J., Hards, D.K., Quinn, J.M.W., Niforas, P., Ng, K.W., Martin, T.J. & Gillespie, M.T. (1999) Localization of RANKL (Receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues. Bone, 25, 525-534.
24. Kelm, R.J., Hair, G.A., Mann, K.G. & Grant, B.W. (1992) Characterization of human osteoblast and megakaryocyte-derived osteonectin (Sparc). Blood, 80, 3112-3119.
25. Kong, Y.Y., Yoshida, H., Sarosi, I., Tan, H.L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A.J., Van, G., Itie, A., Khoo, W., Wakeham, A., Dunstan, C.R., Lacey, D.L., Mak, T.W., Boyle, W.J. & Penninger, J.M. (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature, 397, 315-323.
26. Landshman, N. & Bleiberg, I. (1979) Effect of estradiol on erythropoiesis and megakaryocytopoiesis in mice. Israel Journal of Medical Science, 15, 140-146.
27. Li, J., Sarosi, I., Yan, X.-Q., Morony, S., Capparelli, C., Tan, H.-L., McCabe, S., Elliott, R., Scully, S., Van, G., Kaufman, S., Juan, S.-C., Sun, Y., Tarpley, J., Martin, L., Christensen, K., McCabe, J., Kostenuik, P., Hsu, H., Fletcher, F., Dunstan, C.R., Lacey, D.L. & Boyle, W.J. (2000) RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. PNAS, 97, 1566-1571.
28. Pearse, R.N., Sordillo, E.M., Yaccoby, S., Wong, B.R., Liau, D.F., Colman, N., Michaeli, J., Epstein, J. & Choi, Y. (2001) Multiple myeloma disrupts the TRANCE/osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression. Proceedings of the National Academy of Sciences of the United States of America, 98, 11581-11586.
29. Perry, M.J., Samuels, A., Bird, D. & Tobias, J.H. (2000) Effects of high-dose estrogen on murine hematopoietic bone marrow precede those on osteogenesis. American Journal of Physiology-Endocrinology and Metabolism, 279, E1159-E1165.
30. Samuels, A., Perry, M.J. & Tobias, J.H. (1998) Analysis of the relationship between oestrogen induced osteosclerosis and changes in megakaryocyte populations in female mice. Journal of Bone and Mineral Research, 13, O16.
31. Samuels, A., Perry, M.J. & Tobias, J.H. (1999) High-dose estrogen-induced osteogenesis in the mouse is partially suppressed by indomethacin. Bone, 25, 675-680.
32. Simonet, W.S., Lacey, D.L., Dunstan, C.R., Kelley, M., Chang, M.S., Luthy, R., Nguyen, H.Q., Wooden, S., Bennett, L., Boone, T., Shimamoto, G., DeRose, M., Elliott, R., Colombero, A., Tan, H.L., Trail, G., Sullivan, J., Davy, E., Bucay, N., RenshawGegg, L., Hughes, T.M., Hill, D., Pattison, W., Campbell, P., Sander, S., Van, G., Tarpley, J., Derby, P., Lee, R. & Boyle, W.J. (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell, 89, 309-319.
33. Tarantino, M.D., Kunicki, T.J. & Nugent, D.J. (1994) The estrogen-receptor is present in human megakaryocytes. Annals of the New York Academy of Sciences, 714, 293-296.
34. Thiede, M.A., Smock, S.L., Petersen, D.N., Grasser, W.A., Thompson, D.D. & Nishimoto, S.K. (1994) Presence of messenger-ribonucleic-acid encoding osteocalcin, a marker of bone turnover, in bone-marrow megakaryocytes and peripheral-blood platelets. Endocrinology, 135, 929-937.
35. Tsai, M.-J., Clark, J.H., Schrader, W.T. & O'Malley, B.W. (1998) Mechanisms of action of hormones that act as transcription factors. In: Textbook of Endocrinolgy (ed. by J.D. Wilson, D.W. Foster, H.M. Kronenburg & P.R. Larsen), pp. 55-94. Saunders WB, Philadelphia.
36. Tsuda, E., Goto, M., Mochizuki, S., Yano, K., Kobayashi, F., Morinaga, T. & Higashio, K. (1997) Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochemical and Biophysical Research Communications, 234, 137-142.
37. Turner, R.T., Riggs, B.L. & Spelsberg, T.C. (1994) Skeletal effects of estrogen. Endocrine Reviews, 15, 275-300.
38. Vedi, S. & Compston, J.E. (1996) The effects of long-term hormone replacement therapy on bone remodeling in postmenopausal women. Bone, 19, 535-539.
39. Vedi, S., Purdie, D.W., Ballard, P., Bord, S., Cooper, A.C. & Compston, J.E. (1999) Bone remodeling and structure in postmenopausal women treated with long-term, high-dose estrogen therapy. Osteoporosis International, 10, 52-58.
40. Wahab, M., Ballard, P., Purdie, D.W., Cooper, A. & Willson, J.C. (1997) The effect of long term oestradiol implantation on bone mineral density in postmenopausal women who have undergone hysterectomy and bilateral oophorectomy. British Journal of Obstetrics and Gynaecology, 104, 728-731.